Manjusha Keni

Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial

Eric Lim, David Waller, Kelvin Lau et al. · The Lancet Respiratory Medicine · 2024 · 119 citations · Full text

Medicine, Oncology, Surgery +14

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado‐Barrera et al. · Radiotherapy and Oncology · 2019 · 96 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma

Eric Lim, Liz Darlison, John Edwards et al. · BMJ Open · 2020 · 80 citations · Full text

Medicine, Oncology, Surgery +17

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres

Prashanth Sanganalmath, J. Lester, Alexander Bradshaw et al. · Clinical Oncology · 2018 · 11 citations

Medicine, Oncology, Radiation Oncology +13